−1.66HKD
−632.01 MHKD
160.43 M
About JIANGSU RECBIO TECHNOLOGY CO LTD
Sector
CEO
Yong Liu
Website
Headquarters
Taizhou
Employees (FY)
472
Founded
2012
ISIN
CNE1000057K9
FIGI
BBG0167SQCG4
Jiangsu Recbio Technology Co., Ltd. engages in the research and development of vaccines. It focuses on innovative technology platforms such as novel adjuvant, protein engineering, and immunological evaluation platforms. The company was founded by Yong Liu on May 18, 2012 and is headquartered in Taizhou City, China.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 2179 is 9.17 HKD — it has decreased by 1.19% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange JIANGSU RECBIO TECHNOLOGY CO LTD stocks are traded under the ticker 2179.
JIANGSU RECBIO TECHNOLOGY CO LTD is going to release the next earnings report on Aug 23, 2024. Keep track of upcoming events with our Earnings Calendar.
Yes, you can track JIANGSU RECBIO TECHNOLOGY CO LTD financials in yearly and quarterly reports right on TradingView.
Like other stocks, 2179 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade JIANGSU RECBIO TECHNOLOGY CO LTD stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 16, 2024, the company has 472.00 employees. See our rating of the largest employees — is JIANGSU RECBIO TECHNOLOGY CO LTD on this list?